## Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells* Epstein-Barr virus-transformed human B cells (EBV-B cells), but not resting B cells or B cells activated by T cell-derived factors, have been shown to support the proliferation of tetanus
Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein–Barr virus
✍ Scribed by Banerjee, Subrata; Livanos, Elizabeth; Vos, Jean-Michel H.
- Book ID
- 109932649
- Publisher
- Nature Publishing Group
- Year
- 1995
- Tongue
- English
- Weight
- 820 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1078-8956
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Individuals infected with the human immunodeficiency virus (HIV), the etiologic agent of acquired immunodeficiency syndrome (AIDS), often show symptoms associated with reactivation of Epstein-Barr virus (EBV). In this study, we show that exposure of EBV-positive B lymphocytes to HIV-I in vitro induc
## Abstract Four Epstein‐Barr virus‐positive lymphoblastoid cell lines (LCL) were successfully infected __in vitro__ with immunodeficiency virus type 1 (HIV‐1) as demonstrated by reverse transcriptase activity and p24 HIV antigen in culture supernatants, positive cell staining for gag‐encoded HIV p